stockrowArrowhead Pharmaceuticals, Inc. (ARWR) vs TG Therapeutics, Inc. (TGTX)
- Arrowhead Pharmaceuticals, Inc. ARWR 58.01 +0.96%
- TG Therapeutics, Inc. TGTX 59.60 +2.79%
Arrowhead Pharmaceuticals, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and TG Therapeutics, Inc. are of similar size ($8.9B and $8.1B). Arrowhead Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; TG Therapeutics, Inc. trades at 19.6×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 16.1%. TG Therapeutics, Inc. has the higher net margin (55.2% vs −47.8%) and the higher return on invested capital (10.7% vs 0.00%). Across the 18 metrics below, TG Therapeutics, Inc. leads on 15 and Arrowhead Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ARWR | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.37% | 68.51% |
| Operating margin | (33.82%) | 17.05% | 0.00% |
| Net margin | (47.79%) | 55.22% | 0.00% |
| Free cash flow margin | (11.22%) | 2.17% | 0.00% |
| Return on equity | (64.91%) | 100.28% | (51.96%) |
| Return on assets | (18.32%) | 37.70% | (46.06%) |
| Return on invested capital | 0.00% | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack